- Home
- GETY vs TERN Comparison
GETY vs TERN Comparison
Compare GETY & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GETY
- TERN
- Stock Information
- Founded
- GETY 1995
- TERN 2017
- Country
- GETY United States
- TERN United States
- Employees
- GETY N/A
- TERN N/A
- Industry
- GETY Industrial Machinery/Components
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- GETY Industrials
- TERN Health Care
- Exchange
- GETY Nasdaq
- TERN Nasdaq
- Market Cap
- GETY 867.0M
- TERN 710.6M
- IPO Year
- GETY N/A
- TERN 2021
- Fundamental
- Price
- GETY $1.72
- TERN $20.52
- Analyst Decision
- GETY Hold
- TERN Buy
- Analyst Count
- GETY 6
- TERN 11
- Target Price
- GETY $4.76
- TERN $21.19
- AVG Volume (30 Days)
- GETY 8.5M
- TERN 4.5M
- Earning Date
- GETY 11-10-2025
- TERN 11-10-2025
- Dividend Yield
- GETY N/A
- TERN N/A
- EPS Growth
- GETY N/A
- TERN N/A
- EPS
- GETY N/A
- TERN N/A
- Revenue
- GETY $946,327,000.00
- TERN N/A
- Revenue This Year
- GETY $2.35
- TERN N/A
- Revenue Next Year
- GETY $3.07
- TERN N/A
- P/E Ratio
- GETY N/A
- TERN N/A
- Revenue Growth
- GETY 3.10
- TERN N/A
- 52 Week Low
- GETY $1.25
- TERN $1.87
- 52 Week High
- GETY $3.87
- TERN $21.03
- Technical
- Relative Strength Index (RSI)
- GETY 37.35
- TERN 79.83
- Support Level
- GETY $1.64
- TERN $7.87
- Resistance Level
- GETY $1.92
- TERN $21.74
- Average True Range (ATR)
- GETY 0.24
- TERN 1.43
- MACD
- GETY -0.04
- TERN 1.10
- Stochastic Oscillator
- GETY 4.55
- TERN 89.47
About GETY Getty Images Holdings Inc.
Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.